NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Apple (AAPL) was downgraded at BTIG Research from Buy to Neutral. Valuation call, as postpaid wireless growth may not be sustainable, BTIG said.
AVEO Pharmaceuticals (AVEO) was downgraded to sell at TheStreet Ratings.
Evercore Partners (EVR) was downgraded from Buy to Neutral at Bank of America/Merrill Lynch. $31 price target. Estimates were also cut, given a lower sales pipeline, BofA/Merrill said.F5 Networks (FFIV) was downgraded from Buy to Hold at Stifel Nicolaus. Valuation call. Genco Shipping & Trading (GNK) was downgraded to sell at TheStreet Ratings. Helmerich & Payne (HP) was upgraded at Guggenheim from Neutral to Buy. $70 price target. Estimates also boosted, given higher expected utilization and dayrates, Guggenheim said. LinkedIn (LNKD) was initiated with a Hold rating at Needham. Valuation call. Molina Healthcare (MOH) was downgraded at Cantor Fitzgerald from Buy to Hold. Valuation call, as the company lost out in the Ohio Medicaid contract, Cantor said. SBA Communications (SBAC) was upgraded at Citigroup to Buy from Neutral. $60 price target. Recent transactions create a surprising valuation discount, Citi said. Tyco (TYC) was upgraded at Argus Research from Hold to Buy. $65 price target. Pentair deal should help both companies, Argus said.
Stock Comments / EPS ChangesEMC (EMC) price target and estimates were raised at Stifel Nicolaus. Shares are now seen reaching $36. Estimates were also increased, following solid channel checks. Buy rating. Eastman Chemical (EMN) was added to the Conviction Buy List at Goldman Sachs. Company is leveraged to lower propane prices, Goldman said. $64 price target. IAC/InterActiveCorp (IACI) estimates were lowered at Oppenheimer through 2013. Change to segment reporting. Outperform rating. Liquidity Services (LQDT) numbers were raised at Oppenheimer. Shares are now seen reaching $57. Estimates were also raised on continued acquisition growth, Oppenheimer said. Outperform rating. MasterCard (MA) estimates and price target were boosted at Stifel Nicolaus. Shares are now seen reaching $505. Estimates were also increased, given higher expected spending volumes, Stifel said. Monsanto (MON) was cut from the Conviction Buy List at Goldman Sachs. Company lacks near-term catalysts, Goldman said. $90 price target. Polycom (PLCM) price target was cut at Citigroup to $19. Negative preannouncement with limited details, Citi said. Buy rating. Parametric (PMTC) estimates, price target were cut at ThinkEquity. Shares are now seen reaching $31. Estimates were also reduced, given inconsistent sales results, ThinkEquity said. Buy rating.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV